Drug therapy for persons with developmental disabilities: Legislation and litigation

Nirbhay N. Singh, Thomas F. Guernsey, Cynthia R. Ellis

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Given the current Zeitgeist that psychologists be granted medication prescription privileges, it is important that as clinicians they be aware of the legislation and litigation that currently provide guidelines for the use of psychotropic drugs. Recent legislation and litigation arising from the use of psychotropic drugs with persons who are developmentally disabled are used as the basis for discussion, although the implications cover all clinical populations typically served by psychologists for whom medication may be a viable treatment option. At present, institutions, physicians, and drug companies can be held legally and financially liable for injuries resulting from the use and misuse of psychotropic medication. The same conditions will apply to psychologists if or when they begin prescribing medication.

Original languageEnglish (US)
Pages (from-to)665-679
Number of pages15
JournalClinical Psychology Review
Volume12
Issue number7
DOIs
StatePublished - Jan 1 1992
Externally publishedYes

Fingerprint

Developmental Disabilities
Jurisprudence
Disabled Persons
Legislation
Psychotropic Drugs
Psychology
Drug Therapy
Occupational Health Physicians
Prescriptions
Guidelines
Wounds and Injuries
Pharmaceutical Preparations
Population
Therapeutics

ASJC Scopus subject areas

  • Clinical Psychology
  • Psychiatry and Mental health

Cite this

Drug therapy for persons with developmental disabilities : Legislation and litigation. / Singh, Nirbhay N.; Guernsey, Thomas F.; Ellis, Cynthia R.

In: Clinical Psychology Review, Vol. 12, No. 7, 01.01.1992, p. 665-679.

Research output: Contribution to journalArticle

@article{78ed14261b494e8fb839bfc97c3f82ec,
title = "Drug therapy for persons with developmental disabilities: Legislation and litigation",
abstract = "Given the current Zeitgeist that psychologists be granted medication prescription privileges, it is important that as clinicians they be aware of the legislation and litigation that currently provide guidelines for the use of psychotropic drugs. Recent legislation and litigation arising from the use of psychotropic drugs with persons who are developmentally disabled are used as the basis for discussion, although the implications cover all clinical populations typically served by psychologists for whom medication may be a viable treatment option. At present, institutions, physicians, and drug companies can be held legally and financially liable for injuries resulting from the use and misuse of psychotropic medication. The same conditions will apply to psychologists if or when they begin prescribing medication.",
author = "Singh, {Nirbhay N.} and Guernsey, {Thomas F.} and Ellis, {Cynthia R.}",
year = "1992",
month = "1",
day = "1",
doi = "10.1016/0272-7358(92)90019-5",
language = "English (US)",
volume = "12",
pages = "665--679",
journal = "Clinical Psychology Review",
issn = "0272-7358",
publisher = "Elsevier Inc.",
number = "7",

}

TY - JOUR

T1 - Drug therapy for persons with developmental disabilities

T2 - Legislation and litigation

AU - Singh, Nirbhay N.

AU - Guernsey, Thomas F.

AU - Ellis, Cynthia R.

PY - 1992/1/1

Y1 - 1992/1/1

N2 - Given the current Zeitgeist that psychologists be granted medication prescription privileges, it is important that as clinicians they be aware of the legislation and litigation that currently provide guidelines for the use of psychotropic drugs. Recent legislation and litigation arising from the use of psychotropic drugs with persons who are developmentally disabled are used as the basis for discussion, although the implications cover all clinical populations typically served by psychologists for whom medication may be a viable treatment option. At present, institutions, physicians, and drug companies can be held legally and financially liable for injuries resulting from the use and misuse of psychotropic medication. The same conditions will apply to psychologists if or when they begin prescribing medication.

AB - Given the current Zeitgeist that psychologists be granted medication prescription privileges, it is important that as clinicians they be aware of the legislation and litigation that currently provide guidelines for the use of psychotropic drugs. Recent legislation and litigation arising from the use of psychotropic drugs with persons who are developmentally disabled are used as the basis for discussion, although the implications cover all clinical populations typically served by psychologists for whom medication may be a viable treatment option. At present, institutions, physicians, and drug companies can be held legally and financially liable for injuries resulting from the use and misuse of psychotropic medication. The same conditions will apply to psychologists if or when they begin prescribing medication.

UR - http://www.scopus.com/inward/record.url?scp=0026574849&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026574849&partnerID=8YFLogxK

U2 - 10.1016/0272-7358(92)90019-5

DO - 10.1016/0272-7358(92)90019-5

M3 - Article

AN - SCOPUS:0026574849

VL - 12

SP - 665

EP - 679

JO - Clinical Psychology Review

JF - Clinical Psychology Review

SN - 0272-7358

IS - 7

ER -